Introduction of the interferon γ gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2D(k) and concomitant enhanced metastasis

Cancer Immunology Immunotherapy

Volumn 42, Issue 6, 1996, Pages 329-338

  Geldhof, Anja B ^a   VandenDriessche, Thierry ^a   Opdenakker, Ghislain ^b   De Baetselier, Patrick ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

IFN ; Metastasis; MHC class I; NK cells; Transfection

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; LYMPHOKINE ACTIVATED KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANIMALS; ANTIGENS, NEOPLASM; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MICE; MICE, INBRED AKR; MICE, SCID; SENSITIVITY AND SPECIFICITY; TRANSFECTION; UP-REGULATION;

EID: 0029796490     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050290     Document Type: Article

References (46)

1. Chadwick BS, Miller RG (1992) Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol 148: 230
2. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156
3. Ciccone E, Pende D, Vitale M, Nanni C, Di Donato C, Bottino C, Morelli L, Viale O, Amoroso A, Moretta A, Moretta L (1994) Self class I molecules protect normal cells from lysis mediated by autologous killer cells. Eur J Immunol 24: 1003
4. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA, Strominger JL, Pober JS (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 81: 4917
5. De Baetselier P, Katzav S, Gorelik E, Feldman M, Segal S (1980) Differential expression of H-2 gene products in tumor cells is associated with their metastatic properties. Nature 288: 179
6. b gene transfections in B16 melanoma differently affect non-immunological properties relevant to the metastatic process. Involvement of integrin molecules. Int J Cancer 59: 269
7. Doherty PC, Knowless BB, Wettstein PJ (1984) Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res 42: 1
8. Eisenbach L, Segal S, Feldman M (1983) MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int J Cancer 32: 113
9. Franksson L, Petersson M, Kiessling R, Kärre K (1993) Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur J Immunol 23: 2606
10. Gallatin WM, Weissman IL, Butcher EC (1983) A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304: 30
11. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990) Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820
12. Greenberg PD, Cheever MA, Fefer A (1981) H-2 restriction of adaptive immunotherapy of advanced tumors. J Immunol 126: 2100
13. Haliotis T, Carlow DA, Elliott BE (1990) Non-immunological aspects of MHC function in the regulation of cell proliferation and the malignant phenotype. Cancer Cells 2: 86
14. Karlhofer FM, Ribaudo RK, Yokoyama WY (1992) MHC class I alloantigen specificity of Ly-49+ IL-2 activated natural killer cells. Nature 358: 66
15. Kärre K (1991) MHC gene control of the natural killer system at the level of the target and the host. Semin Cancer Biol 2: 295
16. Kärre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of MHC deficient lymphoma variants suggests alternative immune defense strategy. Nature 319: 675
17. Katzav S, De Baetselier P, Tartakovsky B, Feldman M, Segal S (1983) Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from non-metastatic to metastatic cells. J Natl Cancer Inst 71: 317
18. Ljunggren H-G, Kärre K (1990) In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 11: 237
19. Lollini P-L, Bosco MC, Cavallo F, De Giovanni C, Giovarelli M, Landuzzi L, Musiani P, Modesti A, Nicoletti G, Palmieri G, Santoni A, Young HA, Forni G, Nanni P (1993) Inhibition of tumor growth and enhanced metastasis after transfection of the γ-interferon gene. Int J Cancer 55: 320
20. Maio M, Gulwani B, Tombesi S, Langer JA, Duigou GJ, Kerbel RS, Fisher PB, Ferrone S (1988) Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10. J Immunol 141: 913
21. Malek TR, Robb RJ, Shevach EM (1983) Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex. Proc Natl Acad Sci USA 80: 5694
22. Mareel MM, De Baetselier P, Van Roy FM (1991) Mechanisms of invasion and metastasis. CRC, Boca Raton, Fla, p 7
23. Marschak-Rothstein A, Fink P, Gridley T, Raulet D, Bevan M, Gefter M (1979) Properties and applications of monoclonal antibodies derived against determinants of the Thy1 locus. J Immunol 122: 2491
24. Ogasawara M, Rosenberg SA (1993) Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with γ-interferon genes. Cancer Res 53: 3561
25. Oi V, Jones P, Goding L, Herzenberg L, Herzenberg L (1978) Properties of monoclonal antibodies to mouse Ig allotypes, H-2 and Ia antigens. Curr Top Microbiol Immunol 81: 115
26. Ozato K, Mayer N, Sachs DH (1980) Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 124: 533
27. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L (1993) Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells. J Immunol 150: 1458
28. Pross HF, Baines MG (1987) Alterations in natural killer activity in tumor bearing hosts. In: Herberman RB, Wiltrout RH, Gorelik E (eds) Immune responses to metastases, vol 1. CRC, Boca Raton, Fla, p 83
29. + T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 175: 1423
30. Salcedo M, Momburg F, Hammerling GJ, Ljunggren H-G (1994) Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. J Immunol 152: 1702
31. Schwarz DA, Buhlmann JE, Kuhne MR, Tan TM, White WD, Green WR (1993) Novel regulation of a MHC class I response to interferon-γ. Cell Immunol 150: 90
32. Shiloni E, Karp SE, Custer MC, Shilyansky J, Restifo NP, Rosenberg SA, Mulé JJ (1993) Retroviral transduction of interferon γ cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunol Immunother 37: 286
33. Shire D (1993) RT-PCR quantification of mRNA using a multispecific internal standard. Sanofi Recherche, Labége-Innopole Voie I, BP137, 31676 Labége, France
34. Smithson G, Wolcolt RM, Chervenak R (1992) Development of a murine lymphoma model system for the characterization of natural killer: tumor cell interactions. Cancer Res 52: 4149
35. Storkus WJ, Salter RD, Alexander J, Ward FE, Ruiz RE, Cresswell P, Dawson JR (1991) Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acacl Sci USA 88: 5989
36. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A (1990) Sequences encoded in the class II region of the MHC related 'ABC' superfamily of transporters. Nature 348: 741
37. Tuttle TM, McCrady CW, Inge TH, Salour M, Bear HD (1993) γ-Interferon plays a key role in T-cell-induced tumor regression. Cancer Res 53: 833
38. Vandekerckhove F, Darji A, Rivera MT, Carlier Y, Vray B, Billiau A, De Baetselier P (1994) Modulation of T-cell responsiveness during Trypanosoma cruzi infection: analysis in different lymphoid compartments. Parasite Immunol 16: 77
39. VandenDriessche T, Verschueren H, De Baetselier P (1990) Association between MHC class I antigen expression and malignancy of murine T lymphoma variants. Invasion Metastasis 10: 65
40. k antigens. Clin Exp Metastasis 12: 73
41. k antigens. Int J Cancer 58: 217
42. Wallach D, Fellous M, Revel M (1982) Preferential effect of interferon-gamma on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299: 833
43. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E-I, Taniyama T, Sakata T-A (1989) Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci USA 86: 9456
44. Welsh RM, Kärre K, Hansson M, Kunkel LA, Kiessling RW (1981) Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. J Immunol 126: 219
45. Wiltrout RH, Herberman RB, Zhang S-R, Chirigos MA, Ortaldo JR, Green KM JR, Talmadge JE (1985) Role of organ-associated NK cells in decreased formation of experimental metastasis in lung and liver. J Immunol 134: 4267
46. Zöller M, Strubel A, Hämmerling G, Andrighetto G, Raz A, Ben-Ze'ev A (1988) Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread. Int J Cancer 41: 256